Home › Quitting Smoking › NCT05738408

Remote Smoking Cessation in Hospitalized Cardiac Patients

Remote Smoking Cessation in Hospitalized Cardiac Patients: Bridging the Post-discharge

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Patients will be recruited if they:

1. Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
2. live within 30 miles of UVMMC and are \>18 years of age
3. Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \>5 cigarette/day on average over the past 3 months)

Exclusion Criteria:

Patients will be excluded if they have:

1. severe dementia/Alzheimer's disease
2. an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
3. exercise limiting vascular or neuromuscular disease
4. Non-English Speaking
5. No reliable smart-phone
6. Current, regular use of smokeless tobacco or other form of non-combusted tobacco

About the study

The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects. The proposed trial can provide significant knowledge for promoting adherence to smoking cessation guidelines in patients with cardiac disease

What is being tested

• Financial Incentives (FI) and Nicotine Replacement Therapy (NRT) (behavioral)

Sponsor: University of Vermont Medical Center · Participants: 50 · Started: Aug 12, 2022

Contact the study team

• Sherrie Khadanga, MD · Phone: 802-847-2700

Official record on ClinicalTrials.gov — NCT05738408

Locations in the U.S.

Conditions

• Quitting Smoking

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.